A-211 - Toward Safe Discontinuation of Immunotherapy in Melanoma: A Multimodal Predictive Model for Relapse Risk

EJC Skin Cancer · Elsevier

Аннотация

Publication date: 2026 Source: EJC Skin Cancer, Volume 4, Supplement 1 Author(s): K.-W. Noh, Y. Tolkach, D. Helbig, V.M. Barroso, Y. Foerster, M. Schlaak, T. Biedermann, R. Büttner, O.-D. Persa

Читать у издателя →

Похожие статьи